New drug trial offers hope for stiff, painful back condition
Disease control
Recruiting now
This study is testing an investigational drug called LNK01001 for adults with active ankylosing spondylitis, a condition causing back pain and stiffness. For 16 weeks, about 350 participants will receive either the drug or a placebo pill twice daily to see if LNK01001 is better a…
Phase: PHASE3 • Sponsor: Lynk Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC